Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Clinical trial NCT02628236 · COMPLETED
Trial details
- NCT number
- NCT02628236
- Sponsor
- DUSA Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.